USPTO serial 78117254
GTC PHARMACEUTICALS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAYS, PAULA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GTC PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DEBRA S. SEROTA,
CYNTHIA JOHNSON WALDEN, FISH & RICHARDSOPO BOX 1022MINNEAPOLIS, MN 55440-1022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | -- Reagents for use in scientific or medical research; purified and organic proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use in the manufacture of pharmaceuticals and reagents; purified and organic proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms and for use in scientific or medical research; cells, cell lines and cell cultures for use in scientific and medical research; transgenic and cloned animal products, namely meat, tissue, cells or secretions for use in scientific or medical research | ACTIVE | — |
| 005 | -- Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use as medical therapeutic reagents; transgenic and cloned animal products, namely, meat, tissue, cells or secretions for therapeutic and diagnostic use | ACTIVE | — |
| 031 | Live laboratory animals and live transgenic animals | ACTIVE | — |
| 040 | Processing and purifying of antithrombin III, recombinant human albumin, decorin, cystic fibrosis transmembrane conductance regulator, prolactin and urokinase obtained from the milk of transgenic animals, and cloned animals for use in medical and scientific research and for therapeutic and diagnostic use; custom manufacture of pharmaceuticals, biopharmaceuticals, proteins, cell culture and transgenic animal products | ACTIVE | — |
| 042 | Providing technical advice, research, testing and analysis in the fields of biotechnology, molecular biology, chemistry, genetics, genetic engineering, pharmaceutical production, isolation of pharmaceutical and nutritive and dietetic substances, genealogy, chemicals, and pharmaceutical drug development; pharmaceutical drug development; medical research services in the nature of medical engineering services and genetic engineering services; isolation of pharmaceutical and nutritive and dietetic substances for research purposes | ACTIVE | — |
| 044 | Isolation of pharmaceutical and nutritive and dietetic substances for medical purposes, medical testing services in the nature of medical engineering and genetic engineering of cloned and transgenic animals; animal breeding; transgenic and cloned animal breeding; animal husbandry, veterinary services; veterinary surgery; providing for the care and use of transgenic or cloned animals and products there from | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genzyme Transgenics Corporation
- Other trademarks owned by Genzyme Transgenics Corporation
- Other trademarks owned by GTC BIOTHERAPEUTICS, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 031
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GTC PHARMACEUTICALS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2007 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 5, 2007 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 13, 2006 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 13, 2006 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 13, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 20, 2005 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 20, 2005 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 20, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 29, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 23, 2005 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 7, 2005 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 7, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 2, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 2, 2004 | CFIT | CASE FILE IN TICRS | — |
| Aug 18, 2004 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Dec 15, 2003 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 28, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 8, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 5, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 29, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 25, 2003 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 31, 2003 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 28, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 27, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 27, 2003 | PAPER RECEIVED | — | |
| Apr 14, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2003 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 14, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 15, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2003 | PAPER RECEIVED | — | |
| Jul 15, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2002 | DOCK | ASSIGNED TO EXAMINER | — |